Fairness opinions › Acquirers
Baxter International: healthcare acquisitions with fairness opinions
2 public-company targets, 2011-2021, $13B combined enterprise value. The multiples Baxter International paid and the banker analyses behind each target board's recommendation.
Deals
2
Median EV / EBITDA paid
17.4x
Median EV / revenue paid
3.60x
| Announced | Target | Acquirer | Segment | EV | EV/EBITDA | EV/Rev | DCF rate | Fairness opinion |
|---|---|---|---|---|---|---|---|---|
| 2021-09-02 | Hill-Rom Holdings | Baxter International | Medical Devices and Supplies | $12B | 17.6x | 3.89x | 7.0%–9.0% | BofA Securities, Goldman Sachs |
| 2011-12-13 | Synovis Life Technologies | Baxter International | Medical Devices and Supplies | $260M | 17.1x | 3.32x | 20.1%–23.3% | Piper Sandler |